
Leyden Labs is a biotechnology company dedicated to developing intranasal prophylactics that target broad viral families to protect against current and emerging respiratory pathogens. Their portfolio of candidate products is designed to provide rapid, accessible protection against influenza, coronavirus, and other respiratory viruses. The company blends deep expertise in infectious disease and immunology with a culture of innovative thinking, drawing on a team of seasoned biotech veterans and emerging talent. By focusing on prevention rather than treatment, Leyden Labs offers individuals immediate, self-administered defense against viral spread, positioning itself as a leader in next-generation respiratory virus countermeasures.
We are looking for a (Sr.) CMC Manager Analytics to support all (pre) clinical projects with respect to production of Leyden Labs products, product quality, and CMC documentation for regulatory dossiers.
Leyden Labs is a biotechnology company dedicated to developing intranasal prophylactics that target broad viral families to protect against current and emerging respiratory pathogens. Their portfolio of candidate products is designed to provide rapid, accessible protection against influenza, coronavirus, and other respiratory viruses. The company blends deep expertise in infectious disease and immunology with a culture of innovative thinking, drawing on a team of seasoned biotech veterans and emerging talent. By focusing on prevention rather than treatment, Leyden Labs offers individuals immediate, self-administered defense against viral spread, positioning itself as a leader in next-generation respiratory virus countermeasures.